🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this prospective study is to explore the safety and preliminary...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2025-01-15
Trial ID
NCT06775743
Treatments Being Tested
Retrospective, non-interventional observational cohort study conducted amon...
Status
Completed
Location
Novartis Investigative Site
Start Date
2021-03-08
Trial ID
NCT05476562
Treatments Being Tested
This trial is testing two novel combinations (temozolomide plus osimertinib...
Status
Completed
Location
University of Colorado Hospital
Start Date
2020-10-29
Trial ID
NCT04541407
Treatments Being Tested
A Randomized, Double-blind, Multi-center, Phase III Clinical Study of AK112...
Status
Active Not Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2022-01-25
Trial ID
NCT05184712
Treatments Being Tested
Improving the quality of life and achieving Treatment-Free Remission(TFR) i...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2022-07-31
Trial ID
NCT05440747
Treatments Being Tested
The study aims to assess treatment patterns and outcomes in advanced RCC pa...
Status
Completed
Location
Pfizer INC
Start Date
2019-12-02
Trial ID
NCT04375150
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of hepatic...
Status
Active Not Recruiting
Location
The first hospital of China medical university
Start Date
2024-08-16
Trial ID
NCT06632106
Evaluation of the efficacy and safety of withdrawal of tyrosine kinase inhi...
Status
Active Not Recruiting
Location
University Hospital Brno
Start Date
2020-06-16
Trial ID
NCT04147533
Treatments Being Tested
There are two different treatment modes for NSCLC patients who failed to ep...
Status
Unknown
Location
Department of Respiratory Medicne, Peking Union Medical Hospital
Start Date
2012-10
Trial ID
NCT01746277
Treatments Being Tested
This phase I/II trial studies the side effects and best dose of ruxolitinib...
Status
Terminated
Location
M D Anderson Cancer Center
Start Date
2013-07-24
Trial ID
NCT01751425
Treatments Being Tested